Martha Finnegan

ORCID: 0000-0002-3727-3497
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Electroconvulsive Therapy Studies
  • Treatment of Major Depression
  • Schizophrenia research and treatment
  • Healthcare Decision-Making and Restraints
  • Tryptophan and brain disorders
  • Mental Health and Psychiatry
  • Bipolar Disorder and Treatment
  • Transcranial Magnetic Stimulation Studies
  • Functional Brain Connectivity Studies
  • Advanced Neuroimaging Techniques and Applications
  • Maternal Mental Health During Pregnancy and Postpartum
  • Ethics in Clinical Research
  • Long-Term Effects of COVID-19
  • Psychotherapy Techniques and Applications
  • Takotsubo Cardiomyopathy and Associated Phenomena
  • Intensive Care Unit Cognitive Disorders
  • Health disparities and outcomes
  • Sirtuins and Resveratrol in Medicine
  • Calcium signaling and nucleotide metabolism
  • Ethics and Legal Issues in Pediatric Healthcare
  • Cardiac Health and Mental Health
  • Vestibular and auditory disorders
  • Circadian rhythm and melatonin
  • Cognitive Abilities and Testing
  • Mental Health Research Topics

Trinity College Dublin
2016-2025

Tallaght University Hospital
2021-2025

St. Patrick's Hospital
2014-2025

Ollscoil na Gaillimhe – University of Galway
2019-2024

St. James's Hospital
2021-2022

Harran University
2018

Yale University
2018

Stefania Tognin Hendrika H. van Hell Kate Merritt Inge Winter-van Rossum Matthijs G. Bossong and 95 more Matthew J. Kempton Gemma Modinos Paolo Fusar‐Poli Andrea Mechelli Paola Dazzan A. Ter Maat Lieuwe de Haan Benedicto Crespo‐Facorro Birte Glenthøj Stephen M. Lawrie Colm McDonald Oliver Gruber Thérèse van Amelsvoort Celso Arango Tilo Kircher Barnaby Nelson Silvana Galderisi Rodrigo A. Bressan Jun Soo Kwon Mark Weiser Romina Mizrahi Gabriele Sachs Anke Maatz René S. Kahn Philip McGuire Philip McGuire Stefania Tognin Paolo Fusar‐Poli Matthew J. Kempton Gemma Modinos Kate Merritt Andrea Mechelli Paola Dazzan George Gifford Natalia Petros Mathilde Antoniades Andrea De Micheli Sandra Vieira Thomas Spencer Cristina Scarpazza Emily Hird René S. Kahn A. Ter Maat Erika van Hell Inge Winter Wiepke Cahn Hugo G. Schnack Lieuwe de Haan Dieuwke Siegmann Jana Barkhof Lotte Hendriks Iris de Wit Benedicto Crespo‐Facorro Diana Tordesillas‐Gutiérrez Esther Setién‐Suero Rosa Ayesa‐Arriola Paula Suárez‐Pinilla MariaLuz Ramirez-Bonilla Víctor Ortiz‐García de la Foz Birte Glenthøj Mikkel Sørensen Karen Tangmose Helle Schæbel Brian V. Broberg Egill Rostrup Stephen M. Lawrie Colm McDonald Brian Hallahan Dara M. Cannon James McLoughlin Martha Finnegan Oliver Gruber Thérèse van Amelsvoort Danny Deckers Machteld Marcelis Claudia Vingerhoets Celso Arango Covadonga M. Díaz‐Caneja Miriam Ayora Joost Janssen Roberto Rodríguez‐Jiménez Marina Dı́az-Marsá Tilo Kircher Irina Falkenberg Florian Bitsch Philipp Berger Jens Sommer Kyeon Raab Babette Jakobi Barnaby Nelson Patrick D. McGorry G. Paul Amminger Meredith McHugh Silvana Galderisi Armida Mucci

In the last 2 decades, several neuroimaging studies investigated brain abnormalities associated with early stages of psychosis in hope that these could aid prediction onset and clinical outcome. Despite advancements field, has yet to deliver. This is part explained by use univariate analytical techniques, small samples lack statistical power, external validation potential biomarkers, integration nonimaging measures (eg, genetic, clinical, cognitive data). PSYSCAN an international,...

10.1093/schbul/sbz067 article EN cc-by-nc Schizophrenia Bulletin 2019-05-30

Abstract Background Older people with depression exhibit better response to electroconvulsive therapy (ECT). We aimed measure the total effect of age on ECT and investigate whether this is mediated by psychotic features, psychomotor retardation, agitation, onset, episode duration. Methods pooled data from four prospective Irish studies where was administered for a major depressive (unipolar or bipolar) baseline score ≥21 24-item Hamilton Depression Rating Scale (HAM-D). The primary outcome...

10.1017/s0033291725000807 article EN Psychological Medicine 2025-01-01

10.1136/jme-2024-110610 article EN Journal of Medical Ethics 2025-02-12

The distinct clinical and radiological characteristics of right temporal variant FTD have only been recently recognized.

10.3390/brainsci14080806 article EN cc-by Brain Sciences 2024-08-11

Objective Depression relapse after electroconvulsive therapy (ECT) is common (40% at 6 months). Ketamine has a robust antidepressant effect, but there are no reported studies of ketamine for depression prevention. This pilot trial (NCT02414932) was designed to assess feasibility the proposed protocol, including examining reasons nonrecruitment, nonrandomization, and dropout. Methods Patients with unipolar referred ECT were monitored weekly therapeutic response, using 24-item Hamilton Rating...

10.1097/yct.0000000000000560 article EN Journal of Ect 2018-12-07

Vulnerable groups are often excluded from clinical research on the basis of scientific, ethical and practical reasons. Although intended to protect vulnerable people maintain study integrity, exclusion through use standard criteria may not always be necessary result in findings that generalisable. Achieving a balance between competing needs make progress our understanding disorders their management requires reconsideration consent processes ensure appropriately represented research. Reasons...

10.1017/ipm.2017.73 article EN Irish Journal of Psychological Medicine 2017-11-27

Major depressive disorder is a common debilitating illness that the second leading contributor to global burden of disease. Unfortunately, about 30 % patients do not respond adequate trials antidepressants and/or psychotherapies. About 45-60 such treatment-resistant will remit with electroconvulsive therapy (ECT). However, relapse rates are high following ECT-38 after 6 months. There need for better prevention strategies. One possibility use ketamine, competitive glutamate receptor...

10.1186/s40814-016-0080-0 article EN cc-by Pilot and Feasibility Studies 2016-08-03

Background Co-prescription of linezolid and serotonergic agents (SSRIs, SNRIs, NaSSA, TCAs) can lead to serotonin syndrome, this study seeks identify prescribing practise these agents. Methods Study all general hospital inpatients prescribed intravenous in a 3-month period, using drug charts clinical notes. Results occurred 20% with SSRIs most frequently concurrently used. There were no cases syndrome. was evidence notes vigilance for potential interaction. Conclusion is common; awareness...

10.1017/ipm.2014.33 article EN Irish Journal of Psychological Medicine 2014-06-30
Margot I. E. Slot Maria F. Urquijo Castro Inge Winter van Rossum Hendrika H. van Hell Dominic Dwyer and 95 more Paola Dazzan A. Ter Maat Lieuwe de Haan Benedicto Crespo‐Facorro Birte Glenthøj Stephen M. Lawrie Colm McDonald Oliver Gruber Thérèse van Amelsvoort Celso Arango Tilo Kircher Barnaby Nelson Silvana Galderisi Mark Weiser Gabriele Sachs Matthias Kirschner Philip McGuire Stefania Tognin Paolo Fusar‐Poli Matthew J. Kempton Alexis E. Cullen Gemma Modinos Kate Merritt Andrea Mechelli George Gifford Natalia Petros Mathilde Antoniades Andrea De Micheli Sandra Vieira Thomas Spencer Zhaoying Yu Dominic Oliver Fiona Coutts Emily Hird Helen Baldwin René S. Kahn Erika van Hell Inge Winter Lieuwe de Haan Frederike Schirmbeck Diana Tordesillas‐Gutiérrez Esther Setién‐Suero Rosa Ayesa‐Arriola Paula Suárez‐Pinilla Víctor Ortiz‐García de la Foz Birte Glenthøj Mikkel Sørensen Bjørn H. Ebdrup Jayachandra M. Raghava Egill Rostrup Brian Hallahan Dara M. Cannon James McLoughlin Martha Finnegan Anja Richter Bernd Krämer Thérèse van Amelsvoort Bea Campforts Machteld Marcelis Claudia Vingerhoets Covadonga M. Díaz‐Caneja Miriam Ayora Joost Janssen Mara Parellada Jessica Merchán‐Naranjo Roberto Rodríguez‐Jiménez Marina Dı́az-Marsá Irina Falkenberg Florian Bitsch Jens Sommer Patrick D. McGorry G. Paul Amminger Christos Pantelis Meredith McHugh Jessica Spark Armida Mucci Paola Bucci Giuseppe Piegari Daria Pietrafesa Alessia Nicita Sara Patriarca Linda Levi Yoav Domany Matthäus Willeit Marcena Lenczowska U Sauerzopf Ana Weidenauer Julia Furtner Daniela Prayer Anke Maatz Achim Burrer Philipp Stämpfli Naemi Huber Stefan Kaiser Wolfram Kawohl

Several multivariate prognostic models have been published to predict outcomes in patients with first episode psychosis (FEP), but it remains unclear whether those predictions generalize independent populations. Using a subset of demographic and clinical baseline predictors, we aimed develop externally validate different predicting functional outcome after FEP the context schizophrenia-spectrum disorder (FES), based on previously cross-validation machine learning pipeline. A crossover...

10.1038/s41537-024-00505-w article EN cc-by-nc-nd Schizophrenia 2024-10-07

Abstract Telomerase, the DNA polymerase responsible for maintaining telomere length, has previously been implicated in depression and response to antidepressant drugs. In this study, we aimed compare telomerase activity peripheral blood mononuclear cells between patients with severe recruited as part of KEEP-WELL Trial (Ketamine Depression Relapse Prevention Following ECT; NCT02414932) age- sex-matched healthy volunteers both at baseline/pre-ECT follow-up 1 month later controls or after a...

10.1007/s00406-021-01294-4 article EN cc-by European Archives of Psychiatry and Clinical Neuroscience 2021-07-15

Objectives Depression can impair decision-making capacity (DMC) for health care decisions. However, it is unclear whether DMC improves after treatments depression such as electroconvulsive therapy (ECT). There limited evidence available on treatment in patients with referred ECT, and unknown ECT has any impact DMC. We hypothesized that will improve severely depressed this change be associated reduced depressive symptom severity. Methods Using the MacArthur Competence Assessment...

10.1097/yct.0000000000000804 article EN Journal of Ect 2021-10-15

Electroconvulsive therapy (ECT) is the most effective treatment for severe depression, with a remission rate of 45–70%. It recommended rapid improvement treatment-resistant episodes or prolonged mania, and catatonia. safe procedure major medical risks are related to anaesthesia. Cognitive adverse effects can be distressing but minimized by use high-dose unilateral ECT; they rarely persist beyond few weeks after course treatment. Repetitive transcranial magnetic stimulation has recently been...

10.1016/j.mpmed.2016.09.009 article EN Medicine 2016-10-27

An abstract is not available for this content so a preview has been provided. Please use the Get access link above information on how to content.

10.1017/ipm.2017.16 article EN Irish Journal of Psychological Medicine 2017-06-05

An abstract is not available for this content so a preview has been provided. Please use the Get access link above information on how to content.

10.1017/ipm.2017.30 article EN Irish Journal of Psychological Medicine 2017-07-10
Coming Soon ...